Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link ...

Patients with systemic lupus erythematosus (SLE) without lupus nephritis (LN) have increased risk of chronic kidney disease ...

Study focuses on interferon blocker's hematologic and serologic benefits ...

Phase 1/2 SSc study is expected to enroll patients at over 20 participating clinical sites in at least five countriesRecently completed Phase 1 ...

Objective SLE is a heterogeneous systemic autoimmune disease with diverse clinical manifestations. We aimed to identify ...

New data presented at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress of the investigational ...

Anaemia is a frequent and clinically relevant complication of systemic lupus erythematosus (SLE), particularly in patients ...

In CAR T-cell therapy, the T cells are removed and modified so when they are back in your body, they attack and destroy the B cells. Dr Oscar highlighted that while this gets rid of the cells ...

Cutaneous lupus erythematosus (CLE) is a complex inflammatory skin disease that presents either in isolation or as a frequent manifestation of systemic lupus erythematosus (SLE). CLE subtypes show ...

In a new study, systemic lupus erythematosus (SLE) disease severity indicated by the presence of lupus nephritis, (LN, lupus-related kidney disease) and other SLE risk factors contributed to reduced ...

A new study published in EULAR Abstract Archive showed that following 48 weeks of therapy, enpatoran, an experimental ...